Patent · US Active

Anti-prolactin receptor antibody formulations

US8883979B2 · kind B2 · utility

9Cited by

20References

26Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Xinghang Ma · Pleasanton, US
Jun Xiang · 红钢城街道, CN
Jianjie Niu · Castro Valley, US

Key dates

Filing date	Mar 15, 2013
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a wide concentration range, especially high concentration, substantially salt-free anti-prolactin receptor antibody formulations that are substantially isosmotic and of low viscosity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.